quinazolines has been researched along with tolbutamide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhaduri, AP; Gupta, CM; Husain, ST; Khanna, NM; Mukherjee, SK | 1 |
| Mukherjee, SK; Murthy, PS; Srivastava, PP | 1 |
| Chen, RJ; Ge, NY; Hao, C; Zhang, DF; Zhang, Y; Zhang, YT; Zhu, GH | 1 |
| Abdulrasool, LI; Endres, CJ; Lee, A; Mayor, JG; Rustia, EL; Sun, H; Topletz-Erickson, A; Walker, L | 1 |
4 other study(ies) available for quinazolines and tolbutamide
| Article | Year |
|---|---|
New potent blood sugar lowering compound.
Topics: Acetates; Animals; Blood Glucose; Hypoglycemic Agents; Injections, Intraperitoneal; Mice; Piperazines; Quinazolines; Rabbits; Rats; Tolbutamide | 1969 |
Efficacy of centpiperalone in combination with biguanide & sulfonylurea.
Topics: Animals; Biguanides; Blood Glucose; Drug Interactions; Glucose Tolerance Test; Glycogen; Hypoglycemic Agents; Islets of Langerhans; Liver; Liver Glycogen; Muscles; Piperazines; Quinazolines; Quinazolinones; Rats; Tolbutamide | 1983 |
Effect of Evodiamine on CYP Enzymes in Rats by a Cocktail Method.
Topics: Administration, Oral; Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Herb-Drug Interactions; Liver; Male; Metoprolol; Midazolam; Omeprazole; Phenacetin; Quinazolines; Rats, Sprague-Dawley; Tolbutamide | 2016 |
Evaluation of Safety and Clinically Relevant Drug-Drug Interactions with Tucatinib in Healthy Volunteers.
Topics: Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Digoxin; Drug Interactions; Gemfibrozil; Healthy Volunteers; Humans; Itraconazole; Midazolam; Oxazoles; Pyridines; Quinazolines; Rifampin; Tolbutamide | 2022 |